Differential Phosphorylation of RhoGDI Mediates the Distinct Cycling of Cdc42 and Rac1 to Regulate Second-phase Insulin Secretion
Overview
Authors
Affiliations
Cdc42 cycling through GTP/GDP states is critical for its function in the second/granule mobilization phase of insulin granule exocytosis in pancreatic islet beta cells, although the identities of the Cdc42 cycling proteins involved remain incomplete. Using a tandem affinity purification-based mass spectrometry screen for Cdc42 cycling factors in beta cells, RhoGDI was identified. RNA interference-mediated depletion of RhoGDI from isolated islets selectively amplified the second phase of insulin release, consistent with the role of RhoGDI as a Cdc42 cycling factor. Replenishment of RhoGDI to RNA interference-depleted cells normalized secretion, confirming the action of RhoGDI to be that of a negative regulator of Cdc42 activation. Given that RhoGDI also regulates Rac1 activation in beta cells, and that Rac1 activation occurs in a Cdc42-dependent manner, the question as to how the beta cell utilized RhoGDI for differential Cdc42 and Rac1 cycling was explored. Co-immunoprecipitation was used to determine that RhoGDI-Cdc42 complexes dissociated upon stimulation of beta cells with glucose for 3 min, correlating with the timing of glucose-induced Cdc42 activation and the onset of RhoGDI tyrosine phosphorylation. Glucose-induced disruption of RhoGDI-Rac1 complexes occurred subsequent to this, coincident with Rac1 activation, which followed the onset of RhoGDI serine phosphorylation. RhoGDI-Cdc42 complex dissociation was blocked by mutation of RhoGDI residue Tyr-156, whereas RhoGDI-Rac1 dissociation was blocked by RhoGDI mutations Y156F and S101A/S174A. Finally, expression of a triple Y156F/S101A/S174A-RhoGDI mutant specifically inhibited only the second/granule mobilization phase of glucose-stimulated insulin secretion, overall supporting the integration of RhoGDI into the activation cycling mechanism of glucose-responsive small GTPases.
Kinesin-1 mediates proper ER folding of the Ca1.2 channel and maintains mouse glucose homeostasis.
Tanaka Y, Farkhondeh A, Yang W, Ueno H, Noda M, Hirokawa N EMBO Rep. 2024; 25(11):4777-4802.
PMID: 39322740 PMC: 11549326. DOI: 10.1038/s44319-024-00246-y.
The Rho guanine dissociation inhibitor α inhibits skeletal muscle Rac1 activity and insulin action.
Moller L, Ali M, Davey J, Raun S, Andersen N, Long J Proc Natl Acad Sci U S A. 2023; 120(27):e2211041120.
PMID: 37364105 PMC: 10318982. DOI: 10.1073/pnas.2211041120.
Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling.
Blandino-Rosano M, Scheys J, Werneck-de-Castro J, Louzada R, Almaca J, Leibowitz G Am J Physiol Endocrinol Metab. 2022; 323(2):E133-E144.
PMID: 35723227 PMC: 9291412. DOI: 10.1152/ajpendo.00076.2022.
DOC2b Enhances β-Cell Function via a Novel Tyrosine Phosphorylation-Dependent Mechanism.
Bhowmick D, Aslamy A, Bhattacharya S, Oh E, Ahn M, Thurmond D Diabetes. 2022; 71(6):1246-1260.
PMID: 35377441 PMC: 9163558. DOI: 10.2337/db21-0681.
Kowluru A, Gleason N Biochem Pharmacol. 2021; 197:114886.
PMID: 34968495 PMC: 8858860. DOI: 10.1016/j.bcp.2021.114886.